Description
An organoiodine compound consisting of uracil having an iodo substituent at the 5-position.
Chemical properties
| Chemical formula | Net charge | Average mass |
|---|---|---|
| C4H3IN2O2 | 0 | 237.98330 |
Nomenclature
| IUPAC | SMILES | InChI | InChIKey |
|---|---|---|---|
| 5-iodopyrimidine-2,4(1H,3H)-dione | Ic1c[nH]c(=O)[nH]c1=O | InChI=1S/C4H3IN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9) | KSNXJLQDQOIRIP-UHFFFAOYSA-N |
Citations
- Béres, J, et al. 1986. Synthesis, structure, and antitumor and antiviral activities of a series of 5-halouridine cyclic 3',5'-monophosphates. Journal of Medicinal Chemistry. 29(4).
- Javaid, ZZ, et al. 1999. Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from Toxoplasma gondii. Biochemical Pharmacology. 58(9).
- Kawaguchi, T, et al. 1988. Potentiation of the antitumor effect of 5-fluoro-2'-deoxyuridine esters in combination with acyclothymidine esters on L1210 in mice via oral administration. Journal of Pharmaceutical Sciences. 77(11).
- Miller, MR, et al. 1986. Interaction of monoclonal antibodies directed against bromodeoxyuridine with pyrimidine bases, nucleosides, and DNA. Journal of Immunology (Baltimore, Md. : 1950). 136(5).